Fingerprint
Dive into the research topics of 'A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically